AFL vs NRIX · P/E 14, rev $18.93B vs rev $54.5M
Aflac Incorporated (AFL) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported AFL revenue for 2024-12-31 was $18.93B. Net income was $5.44B. Revenue was up 401.1% from 2023-12-31 to 2024-12-31. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the AFL and NRIX stock pages for the full models.
Not investment advice.